Bristol-Myers Squibb to Acquire Amylin Pharmaceuticals (BMY, AMLN)
Bristol-Myers Squibb Co. (NYSE: BMY) will acquire Amylin Pharmaceuticals Inc. (NASDAQ: AMLN), the San Diego, California-based biopharmaceutical company, for approximately $5.3 billion in an all cash-transaction. The acquisition would allow BMY to extend its...